Work

Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia

Year: 2024

Type: article

Study design: Observational Study

Source: Medical Oncology

DOI: 10.1007/s12032-024-02302-y

Authors: Ian M. Bouligny, Graeme Murray, Michael Doyel, Tilak Patel, Josh Boron, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Thuy Ho, Kyle Zacholski, Chad Venn, Nolan A. Wages, Steven Grant, Keri R. Maher

Institutions: The University of Texas MD Anderson Cancer Center, VCU Massey Comprehensive Cancer Center, Virginia Commonwealth University, Virginia Commonwealth University Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Virginia Commonwealth University, National Institutes of Health, VCU Massey Cancer Center, National Cancer Institute

Awards: G1569938872, G2302413387, G2524726931, G5430408733, G6027020843, G9000170389, G9000186613, Massey Cancer Center - Cancer Center Support Grant

OpenAlex ID: W4392095183

FWCI: 3.735

Cites: 26

Cited by: 14

Related to: 10